ENST00000574453.5:n.*4259C>G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The ENST00000574453.5(MINK1):​n.*4259C>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0013 in 149,322 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0013 ( 2 hom., cov: 29)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

MINK1
ENST00000574453.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.145

Publications

0 publications found
Variant links:
Genes affected
MINK1 (HGNC:17565): (misshapen like kinase 1) This gene encodes a serine/threonine kinase belonging to the germinal center kinase (GCK) family. The protein is structurally similar to the kinases that are related to NIK and may belong to a distinct subfamily of NIK-related kinases within the GCK family. Studies of the mouse homolog indicate an up-regulation of expression in the course of postnatal mouse cerebral development and activation of the cJun N-terminal kinase (JNK) and the p38 pathways. [provided by RefSeq, Mar 2016]
CHRNE (HGNC:1966): (cholinergic receptor nicotinic epsilon subunit) Acetylcholine receptors at mature mammalian neuromuscular junctions are pentameric protein complexes composed of four subunits in the ratio of two alpha subunits to one beta, one epsilon, and one delta subunit. The acetylcholine receptor changes subunit composition shortly after birth when the epsilon subunit replaces the gamma subunit seen in embryonic receptors. Mutations in the epsilon subunit are associated with congenital myasthenic syndrome. [provided by RefSeq, Sep 2009]
CHRNE Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: Illumina
  • congenital myasthenic syndrome 4A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • congenital myasthenic syndrome 4B
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • congenital myasthenic syndrome 4C
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 17-4897878-C-G is Benign according to our data. Variant chr17-4897878-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 323949.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 194 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MINK1NM_153827.5 linkc.*591C>G 3_prime_UTR_variant Exon 32 of 32 ENST00000355280.11 NP_722549.2 Q8N4C8-1
CHRNENM_000080.4 linkc.*858G>C 3_prime_UTR_variant Exon 12 of 12 ENST00000649488.2 NP_000071.1 Q04844

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MINK1ENST00000355280.11 linkc.*591C>G 3_prime_UTR_variant Exon 32 of 32 1 NM_153827.5 ENSP00000347427.6 Q8N4C8-1
CHRNEENST00000649488.2 linkc.*858G>C 3_prime_UTR_variant Exon 12 of 12 NM_000080.4 ENSP00000497829.1 Q04844

Frequencies

GnomAD3 genomes
AF:
0.00129
AC:
193
AN:
149202
Hom.:
2
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0000732
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000600
Gnomad ASJ
AF:
0.0196
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0138
Gnomad FIN
AF:
0.000302
Gnomad MID
AF:
0.00321
Gnomad NFE
AF:
0.000629
Gnomad OTH
AF:
0.00146
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
674
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
374
African (AFR)
AF:
0.00
AC:
0
AN:
6
American (AMR)
AF:
0.00
AC:
0
AN:
6
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.00
AC:
0
AN:
34
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
234
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
366
Other (OTH)
AF:
0.00
AC:
0
AN:
24
GnomAD4 genome
AF:
0.00130
AC:
194
AN:
149322
Hom.:
2
Cov.:
29
AF XY:
0.00139
AC XY:
101
AN XY:
72828
show subpopulations
African (AFR)
AF:
0.0000730
AC:
3
AN:
41080
American (AMR)
AF:
0.000599
AC:
9
AN:
15020
Ashkenazi Jewish (ASJ)
AF:
0.0196
AC:
67
AN:
3426
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5092
South Asian (SAS)
AF:
0.0141
AC:
66
AN:
4694
European-Finnish (FIN)
AF:
0.000302
AC:
3
AN:
9948
Middle Eastern (MID)
AF:
0.00345
AC:
1
AN:
290
European-Non Finnish (NFE)
AF:
0.000629
AC:
42
AN:
66804
Other (OTH)
AF:
0.00145
AC:
3
AN:
2070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00122
Hom.:
0
Bravo
AF:
0.000986
Asia WGS
AF:
0.00318
AC:
11
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Congenital myasthenic syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.7
DANN
Benign
0.50
PhyloP100
0.14
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375660349; hg19: chr17-4801173; API